Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

The purpose of this study is to find out what effects of using adaptive radiotherapy to deliver chest radiation has on the ability to control lung cancer and side effects.

Trial Details

NCT ID
NCT04952480
Phase
PHASE2
Sponsor
AHS Cancer Control Alberta
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Dose-escalated adaptive radiotherapy
  • Chemotherapy
Locations (sample)
  • Edmonton, Alberta, Canada|53.55014,-113.46871

Key Eligibility Criteria

  • Minimum 18 years of age
  • Biopsy proven, newly diagnosed, untreated SCLC
  • Completed standard of care staging investigations including: CT chest/abdomen/pelvis, bone scan and/or or PET-CT scan, CT head or MRI brain, or che…
  • Eligible for platinum doublet chemotherapy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →